Scientific Review Committee

The PSG SRC reviews all PSG research proposals including retrospective datamining projects and prospective studies, whether observational or interventional.  Reviewers are assigned and the Committee reviews and scores each proposal. The Committee also facilitates contacts with the Mentoring Committee and Working Groups as appropriate. Requests for use of PSG repositories are also reviewed by the SRC. The SRC consists of a chair and co-chair and approximately 10 to 14 members to serve terms of three years rotating off one third of its members every year.

Outline for Review of Proposals Submitted to the PSG

Prior to submitting any proposal to the PSG, we encourage all investigators to make use of the PSG Working Groups and get assistance, if needed, from the PSG Mentoring Committee.

Note: For projects requiring access to the DATATOP biospecimen repository a separate proposal review and funding mechanism has been developed in collaboration with The Michael J. Fox Foundation and supports the identification and validation of novel biomarkers.

  1. Proposal is submitted to PSG and reviewed by PSG Chair/Co-chair

  2. Proposal is assigned a primary and secondary reviewer from the SRC

  3. Primary and secondary reviewers submit their review within 30 days

  4. Proposal and reviews are distributed to the SRC

  5. SRC rates the proposal using the NIH 9-point scoring system. Individual reviewer scores will be averaged and the result multiplied by 10 to determine the final impact/priority score (range of 10 to 90)

  6. Proposal is approved, approved with criticisms, or not approved

  7. Proposals with criticisms are referred to the PSG Executive Committee

Submissions due 30 days before SRC meeting and responses back to proposing investigator within 30 days of SRC meeting. SRC meets 3x/year, every 4 months.

Submissions due: 12/1/16
SRC Meeting: January 2017
Response to PI's: 2/3/17

Submissions due: 4/15/17
SRC Meeting: May 2017
Response to PI's: 6/2/17

Submissions due: 8/4/17
SRC Meeting: September 2017
Response to PI's: 10/2/17

Submissions due: 12/1/17
SRC Meeting: January 2018
Response to PI's: 2/2/18

The Procedures for Submission and Review of Proposals is also available in the New Study Proposal Toolkit.

NeuroNEXT opportunities

NeuroNEXT provides an established infrastructure including a data coordinating center (University of Iowa), Clinical Coordinating Center (Massachusetts General Hospital) and approximately 28 study sites. Funded NeuroNEXT studies will use this infrastructure which includes central IRB and pre-established contractual agreements with all sites. All but 3 NeuroNEXT sites are also Parkinson Study Group sites.

Academics, foundations and industry are eligible to submit proposals to NeuroNEXT. Initially, a brief Study Concept Synopsis is evaluated for mission relevance and feasibility by the NeuroNEXT Executive Committee (NEC). Proposals which are found to be mission relevant, feasible and of sufficient priority are referred to protocol working groups for development of grant applications. The resulting grant application would be submitted for NINDS peer review.

Find the NeuroNEXT Clinical Study Concept Synopsis here: http://www.neuronext.org/

Who Serves on the PSG SRC? 

Download a Word doc of the member list here. 

Chair and Co-chair

Peter A. LeWitt, MD, Co-Chair (2016-2018)
Professor of Neurology, Wayne State University School of Medicine
Director, Parkinson's Disease & Movement Disorders Program
Henry Ford West Bloomfield Hospital
6777 West Maple Road
West Bloomfield, MI 48034
(248) 325-2452     (248) 325-2452     Fax: (248) 325-3115
palewitt@ameritech.net     alternate email: plewitt1@hfhs.org
Contact, if necessary: Julia Wall - jwall1@hfhs.org

Joel Perlmutter, MD, Co-Chair (2016-2018)
Washington University School of Medicine
Department of Neurology
660 South Euclid Box 8111
St Louis, MO 63110
(314) 362-6026     Fax: (314) 362-0168
joel@npg.wustl.edu
Assistant: Susan Donovan donovan@npg.wustl.edu

PF PAIR Research Advocate

To be determined

Statistics

Soeun Kim, Ph.D. (2015-2018)
Division of Biostatistics
University of Texas Health Science Center
School of Public Health, RAS W-940
1200 Pressler Street
Houston, TX 77030
Soeun.Kim@uth.tmc.edu
Download Dr. Kim's bio here.

Sharon Xie, PhD (2016-2019)
Department of Biostatistics and Epidemiology
University of Pennsylvania
Perelman School of Medicine
607 Blockley Hall
423 Guardian Drive
Philadelphia, PA 19104-6021
(215) 573-3867     Fax: (215) 573-4865
sxie@mail.med.upenn.edu
Download Dr. Xie's bio here.

General Clinical

James Boyd, MD (2016-2019)
University of Vermont
1 S. Prospect Street, Arnold 2, Neurology
Burlington, VT 05401
(802) 847-4589     Fax: (802) 847-2461
James.Boyd@uvmhealth.org

Irene Richard, MD (2016-2019)
University of Rochester
919 Westfall Rd.
Building C, Suite 220
Rochester, NY 14618
(585) 341-7500     Fax: (585) 341-7510
irene_richard@urmc.rochester.edu
*Download Dr. Richard's bio here.

Marie Saint-Hilaire, MD (2016-2019)
Boston University Medical Center
Department of Neurology
72 East Concord Street C3
Boston MA 02118
(617) 638-8456     Fax: (617) 638-5334
neuromsh@bu.edu

Basic Science

M. Maral Mouradian, MD (2018-2021)
Robert Wood Johnson Medical School
New Brunswick, NJ

Joseph Savitt, MD (2018-2021)
Private Practice Neurology
Baltimore, MD

Genetics/Genetic Epi

Rachel Saunders-Pullman, MD, MPH (2016-2019)
Associate Professor of Neurology
Icahn Mount School of Medicine at Mount Sinai
Department of Neurology
Mount Sinai Beth Israel Medical Center
10 Union Square East, Suite 5J
New York, NY 10003
(212) 844-8719     Fax: (212) 844-8710
RSaunder@chpnet.org

Marta San Luciano Palenzuela, MD (2018-2021)
University of California, San Francisco
San Francisco, CA

Neuropsychology

Gregory Pontone, MD (2018-2021)
The Johns Hopkins University School of Medicine
Baltimore, MD

Neurosurgery/Surgical Clinical Trials

Philip Starr, MD, PhD (2018-2021)
University of California, San Francisco
San Francisco, CA